{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"apolipoprotein-a-i-deficiency","columns":[{"gene":"","key":"population-66a865a41cd8b401bae2","label":"Apolipoprotein A-I deficiency","mondoId":"MONDO:0700513","onsetQualifier":null,"originColumnKey":"MONDO:0700513/ORPHA:425","originalViews":[{"key":"MONDO:0700513/ORPHA:425","label":"Apolipoprotein A-I deficiency","scopeLabel":"ORPHA:425","sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"recordKeys":["28ef1a65d81eb0b6244fb14021306ceabd5ed3784a18f19dec84ad7966e6dadd","988be83eecaf96aa3a2643f4b5e64b68fd39d8e1e5dbaba00147db3f3ff21af0","9a5cfa616e111586d217ae8b5454d5f488d0d4ed0e4f5012867a12eeb2cb023a","aa01c78f92c29f4a4eff44f149dd57c0d7cde6b8bb7edbd2826a51ca0f5793d7","ae06ca41eb36c85853df7c1a62adeb3e627535175ac18a16fe639ae616cdcaa7","bbd6d28ec08efa1aa895daa39f3e510f939cd9d124d1232c95781b142ce6e9d7","d1477a233a8eba08ec6302ad5e322c0da1ec4ef781711495d846a4bd07c8fb94","d9e3964b1cd196f8a4d82b2b5e2af4a37a2ae7c6b05c2a0445c4c1096e37a387","df20dde8283ad730514115130ee32a406d180d422181a08de1e9d4b983ec59c1"],"recordQualifiers":{},"scopeLabel":"ORPHA:425","sourceIds":["ORPHA:425"],"sourceScope":"Native source population. Automatically eligible unique exact-native equivalence; not clinically reviewed."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-66a865a41cd8b401bae2"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003119","HP:0001681","HP:0002621","HP:0000622","HP:0003233","HP:0007759","HP:0005181"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"orphanet":9}},"features":[{"hpoId":"HP:0003119","label":"Abnormal circulating lipid concentration","primary":true},{"hpoId":"HP:0001681","label":"Angina pectoris","primary":true},{"hpoId":"HP:0002621","label":"Atherosclerosis","primary":true},{"hpoId":"HP:0000622","label":"Blurred vision","primary":true},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":true},{"hpoId":"HP:0007759","label":"Opacification of the corneal stroma","primary":true},{"hpoId":"HP:0005181","label":"Premature coronary artery atherosclerosis","primary":true},{"hpoId":"HP:0001114","label":"Xanthelasma","primary":false},{"hpoId":"HP:0000991","label":"Xanthomatosis","primary":false}],"ledeHtml":"A lipoprotein metabolism disorder characterized biochemically by complete absence of apolipoprotein AI and extremely low plasma high density lipoprotein (HDL) cholesterol, and clinically by corneal opacities and xanthomas complicated with premature coronary heart disease (CHD).","mondoId":"MONDO:0700513","node":{"canonicalSlug":"apolipoprotein-a-i-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"apolipoprotein A-I deficiency","paragraphs":["A lipoprotein metabolism disorder characterized biochemically by complete absence of apolipoprotein AI and extremely low plasma high density lipoprotein (HDL) cholesterol, and clinically by corneal opacities and xanthomas complicated with premature coronary heart disease (CHD)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:425","url":"https://monarchinitiative.org/MONDO:0700513"},"ownColumnKeys":["population-66a865a41cd8b401bae2"],"publication":"published","relationships":[{"kind":"parent","label":"hypoalphalipoproteinemia","mondoId":"MONDO:0017773","slug":"hypoalphalipoproteinemia"},{"kind":"child","label":"hypoalphalipoproteinemia, primary, 1","mondoId":"MONDO:0011393","slug":"familial-hdl-deficiency"},{"kind":"child","label":"hypoalphalipoproteinemia, primary, 2","mondoId":"MONDO:0032766","slug":"hypoalphalipoproteinemia-primary-2"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/28051"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"28ef1a65d81eb0b6244fb14021306ceabd5ed3784a18f19dec84ad7966e6dadd","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005181","is_excluded":false,"label":"Premature coronary artery atherosclerosis","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"988be83eecaf96aa3a2643f4b5e64b68fd39d8e1e5dbaba00147db3f3ff21af0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003119","is_excluded":false,"label":"Abnormal circulating lipid concentration","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a5cfa616e111586d217ae8b5454d5f488d0d4ed0e4f5012867a12eeb2cb023a","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001114","is_excluded":false,"label":"Xanthelasma","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aa01c78f92c29f4a4eff44f149dd57c0d7cde6b8bb7edbd2826a51ca0f5793d7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000622","is_excluded":false,"label":"Blurred vision","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae06ca41eb36c85853df7c1a62adeb3e627535175ac18a16fe639ae616cdcaa7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bbd6d28ec08efa1aa895daa39f3e510f939cd9d124d1232c95781b142ce6e9d7","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001681","is_excluded":false,"label":"Angina pectoris","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d1477a233a8eba08ec6302ad5e322c0da1ec4ef781711495d846a4bd07c8fb94","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007759","is_excluded":false,"label":"Opacification of the corneal stroma","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d9e3964b1cd196f8a4d82b2b5e2af4a37a2ae7c6b05c2a0445c4c1096e37a387","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df20dde8283ad730514115130ee32a406d180d422181a08de1e9d4b983ec59c1","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:425","disease_name":"Apolipoprotein A-I deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000991","is_excluded":false,"label":"Xanthomatosis","onset_id":null,"reference":"ORPHA:425","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700513\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:425</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A lipoprotein metabolism disorder characterized biochemically by complete absence of apolipoprotein AI and extremely low plasma high density lipoprotein (HDL) cholesterol, and clinically by corneal opacities and xanthomas complicated with premature coronary heart disease (CHD).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0700513\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"apolipoprotein-a-i-deficiency","sourceDocuments":[{"name":"MONDO: apolipoprotein A-I deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0700513"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"apolipoprotein A-I deficiency"},"schemaVersion":1}
